Work

Adjuvant sintilimab plus bevacizumab following curative resection of spontaneously ruptured hepatocellular carcinoma: A prospective exploratory phase II study (CLEAR-2).

Year: 2026

Type: article

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2026.44.16_suppl.tps4254

Authors: Yongjun Chen, Huichuan Sun, Yuan Cheng, Feng Ye

Institutions: Shanghai Jiao Tong University, Ruijin Hospital, Fudan University, Zhongshan Hospital, Nanjing General Hospital of Nanjing Military Command, Nanjing University

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7162682817

FWCI:

Cites:

Cited by:

Related to: